Published research

Studied in women with bone loss.

Bone-Viva has been evaluated in published research examining changes in bone mineral density in women with osteopenia or osteoporosis.

Medical Research Archives · 2025

Effectiveness of a Nutraceutical, “Bone-Viva®”, in Stabilizing and Improving Bone Mineral Density in Patients with Osteopenia and Osteoporosis

Ronald Yglesias · Odence De La Rosa · Joanne Sagliani · Norman Gaylis

51

Women included

54–90

Age range

1 year

Follow-up period

DEXA

Bone density assessment

Read the complete methodology, results and conclusions in the published research article.

Read the Published Study

Bone support,
backed by science.

BONE-VIVA! brings together clinical experience, scientific research and nutraceutical formulation in a daily supplement designed specifically around women’s bone health.

01

Formulated by Rheumatologists

Clinical insight sits at the centre of the formulation.

02

Research-Led

Ingredients are selected around established nutritional science.

03

Designed for Women

Developed specifically with long-term female bone health in mind.

04

Daily Support

A consistent nutritional approach intended for ongoing use.

Bio-Available
Nutrients

Non-GMO

Scientifically
Studied

GRAS-Approved
Ingredients

Recommended
By Doctors

Gluten-Free

The expert behind BONE-VIVA!

More than four decades of clinical, research and rheumatology experience sit behind the development of the formula.

Dr. Norman Gaylis

Dr. Norman Gaylis

Rheumatologist

Dr. Gaylis is a board-certified Rheumatologist and Internist with more than 40 years of clinical practice and research experience.

His extensive work in rheumatology, bone health and patient care informs the clinical thinking behind BONE-VIVA! and its approach to long-term bone-health support.

High-Risk Groups for Osteoporosis

Women, Especially Postmenopausal Women

Women are more likely to develop osteoporosis due to the decrease in estrogen levels that occurs during menopause, which can accelerate bone loss.

Older Adults

Age is a significant risk factor. As people age, bone density naturally decreases, making them more susceptible to osteoporosis.

Family History of Osteoporosis

Genetics play a role in bone health. Individuals with a family history of osteoporosis are at greater risk.

Low Body Weight and Small Frame

People with lower body weight and smaller frames tend to have less bone mass to begin with, which can increase the risk of osteoporosis.

Ethnicity

Caucasian and Asian individuals have a higher risk of osteoporosis compared to African American and Hispanic individuals.

Hormonal Imbalances

Conditions that affect hormone levels, such as thyroid disorders, parathyroid disorders, or low levels of sex hormones (estrogen in women and testosterone in men), can increase the risk of osteoporosis.

Nutritional Deficiencies

Low intake of calcium and vitamin D, which are crucial for bone health, can contribute to the development of osteoporosis

Sedentary Lifestyle

Lack of physical activity, particularly weight-bearing and strength-training exercises, can weaken bones over time.

Smoking and Excessive Alcohol Consumption

Smoking and high alcohol intake are known to negatively impact bone health and increase the risk of osteoporosis

Chronic Medical Conditions

Conditions such as rheumatoid arthritis, lupus, celiac disease, and inflammatory bowel disease can increase the risk of osteoporosis.

Parathyroid Disorders

Disorders of the parathyroid glands, which regulate calcium levels in the body, can lead to imbalances that affect bone density and increase the risk of osteoporosis.

Certain Medications

Long-term use of corticosteroids and other medications that affect bone density can increase the risk of developing osteoporosis.

RECOMMENDATION

Osteoporosis is a condition characterized by weakened bones and an increased risk of fractures. Certain groups of people are at a higher risk of developing osteoporosis. Understanding these risk factors can help in taking preventive measures and seeking early treatment to manage bone health effectively.

RECOMMENDATION FOR THE BEST OUTCOME BONE-VIVA SHOULD BE TAKEN DAILY FOR AT LEAST 12 MONTHS .